Hemo Organic Ltd Financials
Company Logo

Hemo Organic Ltd Financial Statement

Hemo Organic Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Sep 2024
RevenueTBA
Operating Expense0.08
Net Profit-0.08
Net Profit MarginTBA
Earning Per Share-0.23
EBIDTA-0.08
Effective Tax RateTBA

Hemo Organic Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual0.02
Operating Expenses Annual0.27
Operating Profit Annual-0.25
Interest Annual0.02
DepreciationTBA
Net Profit Annual-0.26
Tax AnnualTBA

Hemo Organic Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning0.12
Cash Flow from Operations-1.19
Cash Flow from InvestingTBA
Cash Flow from Financing1.20
Cash Flow at the End0.13

Hemo Organic Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)-1,200
PBIT Margin (%)-1,200
PBT Margin (%)58,800
Net PROFIT Margin (%)-1,300
Return On Networth / Equity (%)TBA
Return On Networth /Employed (%)TBA
Return On Assets (%)-52
Total Debt / Equity (X)TBA
Asset Turnover Ratio (%)0.04

Hemo Organic Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual0.00
Total Current Assets Annual0.92
Non Current Assets Annual0.14
Total Shareholders Funds Annual-0.32
Total Assets Annual1.06

Hemo Organic Ltd Earning Calls

No Data Availabe

Get Your FAQs Right

As of Nov 5, 2024, Hemo Organic Ltd has a market capitalization of 3.54 Cr. Value Research classifies it as a Micro-Cap company.
Yes, Hemo Organic Ltd is debt-free with a debt-to-equity ratio of -3.92.
In FY 2023 , Hemo Organic Ltd recorded a total revenue of approximately 0.02 Cr marking a significant milestone in the company's financial performance.
Hemo Organic Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately -0.8% and 0.3% annually, respectively..
Hemo Organic Ltd's current PE ratio is -13.62.
Hemo Organic Ltd's ROCE averaged 50.8% from the FY ending March 2022 to 2024, with a median of -26.7%. It peaked at 341.3% in March 2023, reflecting strong capital efficiency over the period..
Hemo Organic Ltd's latest EBIT is Rs. -0.24 Cr, surpassing the average EBIT of Rs. -0.12 Cr over the 5 years..